Molecular Classification
Cadherin, Type I transmembrane glycoprotein, 7D-cadherins
Other Names
CDH17, Liver-Intestine cadherin, LI-cadherin
Disease Roles
Cadherin-17 Overview
Cadherin-17 (CDH17), also known as Liver-Intestine cadherin (LI-cadherin), is a calcium-dependent, type I transmembrane glycoprotein belonging to the cadherin superfamily. It is primarily expressed in the gastrointestinal tract, pancreatic ducts and liver, where it mediates homotypic cell-cell adhesion and functions as an intestinal proton-dependent peptide transporter. CDH17 is aberrantly overexpressed in several cancers, notably gastric cancer, where it acts as an oncogenic biomarker due to its involvement in tumor growth regulation via apoptosis signaling pathways. It binds via homophilic interactions and has a different adhesion mechanism than classical cadherins.
Mechanism of Action
Biological Functions
Cell-cell adhesion
Calcium-dependent homotypic cell-cell adhesion
Peptide transporter
Maintenance of tissue structure
Morphogenesis
Disease Associations
Cancer
Gastric cancer
Safety Considerations
No safety concerns listed
Associated Biomarkers
Biomarker |
---|
CDH17 overexpression in gastric cancer |